Pliant Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.32

+0.04 (+3.13%)

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 1 8%

Hold 7 58%

Sell 4 33%

Price Target

Analyst Price Target +1,193.9% upside

Low Target $13.48

Average Target $17.08

High Target $25.30

Current Price $1.32

Current
$1.32

Target
$17.08

$13.48 $17.08 avg $25.30

Scenario Analysis

Bear Case

$13.48

921.2%

Low target

Base Case

$17.08

+1,193.9%

Avg target

Bull Case

$25.30

+1,816.7%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$1.95

-32.3% from high

52-Week Low

$1.09

+21.1% from low

Target vs 52W High

$17.08

+775.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%